Initial Treatment Plan for Acute Myocardial Infarction (MI)
The initial treatment for acute myocardial infarction must include immediate oxygen administration, aspirin 160-325 mg, adequate analgesia with morphine, and prompt reperfusion therapy for patients with ST-segment elevation or new left bundle branch block. 1, 2
Immediate Emergency Department Management
On arrival to the emergency department, patients with suspected MI should immediately receive:
For patients with ST-segment elevation ≥1 mV in contiguous leads or new LBBB:
- Immediate reperfusion therapy is indicated 1, 2
- Options include fibrinolytic therapy or primary percutaneous coronary intervention (PCI) 1
- Primary PCI is preferred when available in a timely manner 2
- If primary PCI cannot be performed promptly, fibrinolytic therapy should be administered within 12 hours of symptom onset 2
Pharmacological Therapy
Antiplatelet therapy:
Anticoagulation:
Beta-blockers:
- Early intravenous beta-blocker therapy followed by oral therapy should be initiated in all patients without contraindications 1, 2
- For metoprolol: administer three 5 mg IV boluses at approximately 2-minute intervals, followed by oral metoprolol 50 mg every 6 hours for 48 hours, then 100 mg twice daily maintenance 6
- Beta-blockers should be given regardless of whether reperfusion therapy was administered 1
Nitrates:
Other medications:
Management of Complications
For heart failure:
For cardiogenic shock:
For right ventricular infarction with dysfunction:
For recurrent chest pain:
Common Pitfalls and Caveats
- Delaying reperfusion therapy: Time is myocardium - the greatest benefit occurs when thrombolysis is initiated within 6 hours of symptom onset 1
- Calcium channel blockers: These have not been shown to reduce mortality in acute MI and may be harmful in certain patients 1
- Oral nitrates: Use with caution in acute MI due to inability to titrate the dose in an evolving hemodynamic situation 1
- Aspirin dosing: An initial dose of 162 mg may be as effective as and potentially safer than 325 mg for acute treatment of STEMI 7
- Thrombolytics in non-STEMI: Patients without ST-segment elevation should not receive thrombolytic therapy 1